Cardiovascular history : Patients with established cardiovascular disease may benefit from GLP-1 receptor agonists with proven cardiovascular benefits, such as semaglutide, dulaglutide, or liraglutide, which may influence medication selection and target dosing
Is surgery ever a better option than device use
The real constraint is the in-use window, because the entire vial is committed to a single reconstitution date the moment it is opened
Hands down one of the greatest group of people I had the pleasure of dealing with
GLP-1s Are Lowering the Percentage of Americans With Obesity According to the same poll, the percentage of adults with obesity has also dropped to 37 percent, down from a record high of 39.9 percent in 2022
Every plan is personalized